General MedicationsINJECTIONGeneric
SARENIN
SARALASIN ACETATE
Standard Dose
EQ 0.6MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview SARENIN is listed in Drugs@FDA under application 018009 (NDA).
Marketing status: Discontinued Active ingredient SARALASIN ACETATE Form and strength INJECTABLE;INJECTION - EQ 0.6MG BASE/ML Sponsor PROCTER AND GAMBLE Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview SARENIN is listed in Drugs@FDA under application 018009 (NDA). Marketing status: Discontinued Active ingredient SARALASIN ACETATE Form and strength INJECTABLE;INJECTION - EQ 0.6MG BASE/ML Sponsor PROCTER AND GAMBLE Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.